Schonfeld Strategic Advisors LLC Biodesix Inc Transaction History
Schonfeld Strategic Advisors LLC
- $15 Billion
- Q1 2025
A detailed history of Schonfeld Strategic Advisors LLC transactions in Biodesix Inc stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 18,985 shares of BDSX stock, worth $7,594. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,985
Previous 15,728
20.71%
Holding current value
$7,594
Previous $23,000
52.17%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BDSX
# of Institutions
64Shares Held
45.6MCall Options Held
65.5KPut Options Held
500-
Telemark Asset Management, LLC Boston, MA8.28MShares$3.31 Million0.75% of portfolio
-
Bryn Mawr Trust CO Bryn Mawr, PA6.1MShares$2.44 Million0.03% of portfolio
-
Birchview Capital, LP Burlington, VT5.74MShares$2.29 Million3.25% of portfolio
-
Silverarc Capital Management, LLC4.1MShares$1.64 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.79MShares$1.52 Million0.0% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $16M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...